Senior Director, Advanced Pharmacometrics, Quantitative Pharmacology and Pharmacometrics – Immuno-Oncology (Hybrid or Remote)
Merck
Full-time
other-general
Location
Rahway, NJ, United States
Posted
July 18, 2026
Job Description
**Job Description**
We are seeking an accomplished scientific leader to join the Quantitative Pharmacology and Pharmacometrics – Immuno-Oncology (QP2‑IO) team as **Senior Director** , Advanced Pharmacometrics. QP2‑IO is part of the Global Clinical Development organization and is responsible for clinical pharmacology and pharmacometrics strategy and execution for oncology assets, from candidate nomination through registration.
Our Senior Directors are recognized experts in quantitative drug development and possess a deep, integrated understanding of both the science and the strategic, end‑to‑end dimensions of oncology drug development. Reporting directly to Executive Director and Section Head, QP2‑IO, the Senior Director will lead advanced pharmacometrics strategy and implementation to inform key oncology portfolio decisions.
The ideal candidate is an accomplished scientific leader with deep expertise in oncology drug development and has a proven track record ...
We are seeking an accomplished scientific leader to join the Quantitative Pharmacology and Pharmacometrics – Immuno-Oncology (QP2‑IO) team as **Senior Director** , Advanced Pharmacometrics. QP2‑IO is part of the Global Clinical Development organization and is responsible for clinical pharmacology and pharmacometrics strategy and execution for oncology assets, from candidate nomination through registration.
Our Senior Directors are recognized experts in quantitative drug development and possess a deep, integrated understanding of both the science and the strategic, end‑to‑end dimensions of oncology drug development. Reporting directly to Executive Director and Section Head, QP2‑IO, the Senior Director will lead advanced pharmacometrics strategy and implementation to inform key oncology portfolio decisions.
The ideal candidate is an accomplished scientific leader with deep expertise in oncology drug development and has a proven track record ...